AA
ALPS Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Sell |
50,524
-16,779
| -25% | -$483K | 0.01% | 421 |
|
|
2025
Q1 | $2.26M | Sell |
67,303
-7,682
| -10% | -$258K | 0.01% | 332 |
|
|
2024
Q4 | $3.83M | Buy |
74,985
+14,242
| +23% | +$728K | 0.02% | 264 |
|
|
2024
Q3 | $3.1M | Sell |
60,743
-782
| -1% | -$40K | 0.02% | 290 |
|
|
2024
Q2 | $2.76M | Buy |
61,525
+6,556
| +12% | +$294K | 0.02% | 296 |
|
|
2024
Q1 | $2.57M | Buy |
54,969
+8,944
| +19% | +$419K | 0.02% | 312 |
|
|
2023
Q4 | $1.64M | Buy |
46,025
+5,697
| +14% | +$203K | 0.01% | 366 |
|
|
2023
Q3 | $1.2M | Buy |
40,328
+618
| +2% | +$18.4K | 0.01% | 408 |
|
|
2023
Q2 | $716K | Buy |
39,710
+4,190
| +12% | +$75.5K | 0.01% | 552 |
|
|
2023
Q1 | $570K | Sell |
35,520
-957
| -3% | -$15.4K | 0.01% | 569 |
|
|
2022
Q4 | $668K | Buy |
36,477
+7,151
| +24% | +$131K | 0.01% | 539 |
|
|
2022
Q3 | $576K | Sell |
29,326
-2,414
| -8% | -$47.4K | 0.01% | 568 |
|
|
2022
Q2 | $592K | Sell |
31,740
-17,075
| -35% | -$318K | 0.01% | 552 |
|
|
2022
Q1 | $1.07M | Sell |
48,815
-6,149
| -11% | -$135K | 0.01% | 306 |
|
|
2021
Q4 | $1.56M | Buy |
54,964
+7,528
| +16% | +$214K | 0.02% | 316 |
|
|
2021
Q3 | $999K | Sell |
47,436
-2,080
| -4% | -$43.8K | 0.01% | 388 |
|
|
2021
Q2 | $933K | Sell |
49,516
-10,047
| -17% | -$189K | 0.01% | 408 |
|
|
2021
Q1 | $910K | Buy |
59,563
+126
| +0.2% | +$1.93K | 0.01% | 405 |
|
|
2020
Q4 | $839K | Buy |
59,437
+17,503
| +42% | +$247K | 0.01% | 408 |
|
|
2020
Q3 | $657K | Sell |
41,934
-2,875
| -6% | -$45K | 0.01% | 396 |
|
|
2020
Q2 | $785K | Buy |
44,809
+769
| +2% | +$13.5K | 0.01% | 369 |
|
|
2020
Q1 | $647K | Sell |
44,040
-5,132
| -10% | -$75.4K | 0.01% | 393 |
|
|
2019
Q4 | $1.23M | Buy |
49,172
+955
| +2% | +$24K | 0.01% | 285 |
|
|
2019
Q3 | $725K | Sell |
48,217
-2,308
| -5% | -$34.7K | 0.01% | 375 |
|
|
2019
Q2 | $1.26M | Buy |
+50,525
| New | +$1.26M | 0.01% | 281 |
|